Try our mobile app

General information

Country: UNITED STATES

Sector: Medical Devices

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company"s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
Website: abbott.com


  • Bad financial results growth rate -1.2% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-4.8%)
  • Dividend yield for the last twelve months 1.7%
  • Free cash flow yield 3.2% (LTM)
  • Share price is 50.7% higher than minimum and -0.7% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (30.4x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $65.2 mln (-0.029% of cap.)

Key Financials (Download financials)

Ticker: ABT
Share price, USD:  (+0.7%)135.94
year average price 113.06  


year start price 119.40 2024-02-27

min close price 100.07 2024-07-18

max close price 134.95 2025-02-24

current price 135.94 2025-02-25
Common stocks: 1 746 881 140

Dividend Yield:  1.7%
FCF Yield LTM: 3.2%
EV / LTM EBITDA: 30.4x
EV / EBITDA annualized: 30.8x
Last revenue growth (y/y):  +7.2%
Last growth of EBITDA (y/y):  -9.5%
Historical revenue growth:  -0.4%
Historical growth of EBITDA:  -9.1%
Target EV / EBITDA (hist percentile):
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 237 471
Net Debt ($m): -10
EV (Enterprise Value): 237 461
EBITDA LTM ($m): 7 823
EV / LTM EBITDA: 30.4x
Price to Book: 5.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-02-21prnewswire.com

Abbott Declares 405th Consecutive Quarterly Dividend

2025-02-20zacks.com

Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know

2025-02-19zacks.com

Expanding Diabetes Business Supports ABT Stock, FX Issues Stay

2025-02-13fool.com

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

2025-02-12zacks.com

ABT Stock Jumps 12% Since Q4 Earnings: Time to Invest in Abbott?

2025-02-11zacks.com

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

2025-02-10fool.com

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

2025-02-03fool.com

2 Unstoppable Dividend Stocks That Will Pay You for Life

2025-01-24marketbeat.com

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

2025-01-23benzinga.com

Why Is Abbott Stock Trading Higher On Thursday?
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data